Cerebral serotonin transporter measurements with [11C]DASB: A review on acquisition and preprocessing across 21 PET centres
暂无分享,去创建一个
Rupert Lanzenberger | Claus Svarer | Masanori Ichise | Marios Politis | Mark Slifstein | Mark Lubberink | Stephen C Strother | Vesna Sossi | Federico Turkheimer | Tetsuya Suhara | Ling Feng | Martin Nørgaard | Melanie Ganz | Ramin V Parsey | Gitte M Knudsen | Peter S Talbot | F. Turkheimer | V. Sossi | C. Svarer | S. Strother | R. Parsey | M. Lubberink | E. Rabiner | M. Politis | T. Suhara | M. Ichise | G. Knudsen | M. Slifstein | R. Lanzenberger | M. Nørgaard | M. Ganz | Ling Feng | P. Talbot | Eugenii A Rabiner
[1] L. Keltikangas-Järvinen,et al. Neuroticism Associates with Cerebral in Vivo Serotonin Transporter Binding Differently in Males and Females , 2017, The international journal of neuropsychopharmacology.
[2] G. Kranz,et al. Effects of Selective Serotonin Reuptake Inhibitors on Interregional Relation of Serotonin Transporter Availability in Major Depression , 2017, Front. Hum. Neurosci..
[3] G. Kranz,et al. Altered interregional molecular associations of the serotonin transporter in attention deficit/hyperactivity disorder assessed with PET , 2017, Human brain mapping.
[4] C. Svarer,et al. BDNF val66met association with serotonin transporter binding in healthy humans , 2017, Translational Psychiatry.
[5] D. Greve,et al. Cerebellar heterogeneity and its impact on PET data quantification of 5-HT receptor radioligands , 2017, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[6] S. Houle,et al. Serotonin transporter binding is reduced in seasonal affective disorder following light therapy , 2016, Acta psychiatrica Scandinavica.
[7] J. Luthardt,et al. Effortful control as a dimension of temperament is negatively associated with prefrontal serotonin transporter availability in obese and non‐obese individuals , 2016, The European journal of neuroscience.
[8] Ciprian Catana,et al. Different partial volume correction methods lead to different conclusions: An 18F-FDG-PET study of aging , 2016, NeuroImage.
[9] P. Piccini,et al. Serotonin-to-dopamine transporter ratios in Parkinson disease , 2016, Neurology.
[10] R. Parsey,et al. Positron emission tomography quantification of serotonin transporter binding in medication‐free bipolar disorder , 2016, Synapse.
[11] Claus Svarer,et al. Role of Serotonin Transporter Changes in Depressive Responses to Sex-Steroid Hormone Manipulation: A Positron Emission Tomography Study , 2015, Biological Psychiatry.
[12] F. Turkheimer,et al. Altered serotonin transporter binding potential in patients with obsessive-compulsive disorder under escitalopram treatment: [11C]DASB PET study , 2015, Psychological Medicine.
[13] Jae Sung Lee,et al. Putaminal serotonergic innervation , 2015, Neurology.
[14] Claus Svarer,et al. Functional connectivity of the dorsal and median raphe nuclei at rest , 2015, NeuroImage.
[15] Jean-Dominique Gallezot,et al. Comparison of standardized uptake values with volume of distribution for quantitation of [(11)C]PBR28 brain uptake. , 2015, Nuclear medicine and biology.
[16] Jeong-Hee Kim,et al. Serotonin transporter availability in thalamic subregions in schizophrenia: A study using 7.0-T MRI with [11C]DASB high-resolution PET , 2015, Psychiatry Research: Neuroimaging.
[17] L. Siever,et al. Serotonin transporter availability in impulsive aggressive personality disordered patients: a PET study with [11C]DASB. , 2014, Journal of psychiatric research.
[18] R. Parsey,et al. Quantifying serotonin transporters by PET with [11C]‐DASB before and after interferon‐α treatment , 2014, Synapse.
[19] C. Svarer,et al. In abstinent MDMA users the cortisol awakening response is off-set but associated with prefrontal serotonin transporter binding as in non-users. , 2014, The international journal of neuropsychopharmacology.
[20] Y. Okubo,et al. Occupancy of serotonin transporter by tramadol: a positron emission tomography study with [11C]DASB. , 2014, The international journal of neuropsychopharmacology.
[21] F. Turkheimer,et al. Serotonergic mechanisms responsible for levodopa-induced dyskinesias in Parkinson's disease patients. , 2014, The Journal of clinical investigation.
[22] Hidehiko Takahashi,et al. Occupancy of serotonin and norepinephrine transporter by milnacipran in patients with major depressive disorder: a positron emission tomography study with [(11)C]DASB and (S,S)-[(18)F]FMeNER-D(2). , 2013, The international journal of neuropsychopharmacology.
[23] Brian A. Nosek,et al. Power failure: why small sample size undermines the reliability of neuroscience , 2013, Nature Reviews Neuroscience.
[24] P. M. Rasmussen,et al. Prefrontal serotonin transporter availability is positively associated with the cortisol awakening response , 2013, European Neuropsychopharmacology.
[25] Rasmus R. Paulsen,et al. List-Mode PET Motion Correction Using Markerless Head Tracking: Proof-of-Concept With Scans of Human Subject , 2013, IEEE Transactions on Medical Imaging.
[26] Peter S. Talbot,et al. Pre- and Postsynaptic Serotonergic Differences in Males with Extreme Levels of Impulsive Aggression Without Callous Unemotional Traits: A Positron Emission Tomography Study Using 11C-DASB and 11C-MDL100907 , 2012, Biological Psychiatry.
[27] I. Buvat,et al. A review of partial volume correction techniques for emission tomography and their applications in neurology, cardiology and oncology , 2012, Physics in medicine and biology.
[28] Siegfried Kasper,et al. Prediction of SSRI treatment response in major depression based on serotonin transporter interplay between median raphe nucleus and projection areas , 2012, NeuroImage.
[29] Siegfried Kasper,et al. Normative database of the serotonergic system in healthy subjects using multi-tracer PET , 2012, NeuroImage.
[30] A. Björklund,et al. Serotonin Neuron Loss and Nonmotor Symptoms Continue in Parkinson’s Patients Treated with Dopamine Grafts , 2012, Science Translational Medicine.
[31] L. Marner,et al. Loss of serotonin 2A receptors exceeds loss of serotonergic projections in early Alzheimer's disease: a combined [11C]DASB and [18F]altanserin-PET study , 2012, Neurobiology of Aging.
[32] Swen Hesse,et al. Imaging of the brain serotonin transporters (SERT) with 18F-labelled fluoromethyl-McN5652 and PET in humans , 2012, European Journal of Nuclear Medicine and Molecular Imaging.
[33] Julie C Price,et al. Age, Sex, and Reproductive Hormone Effects on Brain Serotonin-1A and Serotonin-2A Receptor Binding in a Healthy Population , 2011, Neuropsychopharmacology.
[34] J. Steele,et al. A non- synonymous polymorphism in galactose mutarotase (GALM) is associated with serotonin transporter binding potential in the human thalamus: Results of a genome-wide association study , 2010, Molecular Psychiatry.
[35] Marc Laruelle,et al. Serotonin transporter polymorphisms (SLC6A4 insertion/deletion and rs25531) do not affect the availability of 5-HTT to [11C] DASB binding in the living human brain , 2010, NeuroImage.
[36] Masanori Ichise,et al. Reduced serotonin transporter binding in the insular cortex in patients with obsessive–compulsive disorder: A [11C]DASB PET study , 2010, NeuroImage.
[37] Yasuomi Ouchi,et al. Altered Brain Serotonin Transporter and Associated Glucose Metabolism in Alzheimer Disease , 2009, Journal of Nuclear Medicine.
[38] Claus Svarer,et al. High familial risk for mood disorder is associated with low dorsolateral prefrontal cortex serotonin transporter binding , 2009, NeuroImage.
[39] Ronald Boellaard,et al. HRRT Versus HR+ Human Brain PET Studies: An Interscanner Test–Retest Study , 2009, Journal of Nuclear Medicine.
[40] Alan A. Wilson,et al. Elevated serotonin transporter binding in depressed patients with Parkinson's disease: A preliminary PET study with [11C]DASB , 2008, Movement disorders : official journal of the Movement Disorder Society.
[41] P. Cowen,et al. Effects of Citalopram Infusion on the Serotonin Transporter Binding of [11C]DASB in Healthy Controls , 2008, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[42] Russell A. Poldrack,et al. Guidelines for reporting an fMRI study , 2008, NeuroImage.
[43] Christer Halldin,et al. Sex differences in the serotonin 1A receptor and serotonin transporter binding in the human brain measured by PET , 2008, NeuroImage.
[44] P. Cowen,et al. 5-HTT binding in recovered depressed patients and healthy volunteers: a positron emission tomography study with [11C]DASB. , 2007, The American journal of psychiatry.
[45] Masanori Ichise,et al. Elevated Serotonin Transporter Binding in Major Depressive Disorder Assessed Using Positron Emission Tomography and [11C]DASB; Comparison with Bipolar Disorder , 2007, Biological Psychiatry.
[46] R. Parsey,et al. In vivo Quantification of Serotonin Transporters Using [11C]DASB and Positron Emission Tomography in Humans: Modeling Considerations , 2007, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[47] Mark Slifstein,et al. Estimation of serotonin transporter parameters with 11C-DASB in healthy humans: reproducibility and comparison of methods. , 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[48] Ramin V. Parsey,et al. Acute Occupancy of Brain Serotonin Transporter by Sertraline as Measured by [11C]DASB and Positron Emission Tomography , 2006, Biological Psychiatry.
[49] Katsuyuki Tanimoto,et al. Effects of image reconstruction algorithm on neurotransmission PET studies in humans: Comparison between filtered backprojection and ordered subsets expectation maximization , 2006, Annals of nuclear medicine.
[50] S. Tanada,et al. A dose-finding study of duloxetine based on serotonin transporter occupancy , 2006, Psychopharmacology.
[51] Masanori Ichise,et al. PET imaging of serotonin transporters with [11C]DASB: test-retest reproducibility using a multilinear reference tissue parametric imaging method. , 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[52] Zsolt Szabo,et al. Quantitative PET Studies of the Serotonin Transporter in MDMA Users and Controls Using [11C]McN5652 and [11C]DASB , 2005, Neuropsychopharmacology.
[53] Sylvain Houle,et al. Regional distribution of serotonin transporter protein in postmortem human brain: is the cerebellum a SERT-free brain region? , 2005, Nuclear medicine and biology.
[54] D. Lee,et al. Performance evaluation of SIEMENS CTI ECAT EXACT 47 PET scanner USING NEMA NU2-2001 , 2004, IEEE Symposium Conference Record Nuclear Science 2004..
[55] Mark Slifstein,et al. Comparative evaluation of serotonin transporter radioligands 11C-DASB and 11C-McN 5652 in healthy humans. , 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[56] J. John Mann,et al. OS-EM and FBP reconstructions at low count rates: effect on 3D PET studies of [11C] WAY-100635 , 2004, NeuroImage.
[57] Jeih-San Liow,et al. Design of a motion-compensation OSEM list-mode algorithm for resolution-recovery reconstruction for the HRRT , 2003, 2003 IEEE Nuclear Science Symposium. Conference Record (IEEE Cat. No.03CH37515).
[58] Jeih-San Liow,et al. Linearized Reference Tissue Parametric Imaging Methods: Application to [11C]DASB Positron Emission Tomography Studies of the Serotonin Transporter in Human Brain , 2003, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[59] Ronald Boellaard,et al. Attenuation correction of PET activation studies in the presenceof task-related motion , 2003, NeuroImage.
[60] Richard E Carson,et al. Noise Reduction in the Simplified Reference Tissue Model for Neuroreceptor Functional Imaging , 2002, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[61] Paul Kinahan,et al. NEMA NU2-2001 performance results for the GE advance PET system , 2002, 2002 IEEE Nuclear Science Symposium Conference Record.
[62] N. Sato,et al. A new high resolution PET scanner dedicated to brain research , 2001, 2001 IEEE Nuclear Science Symposium Conference Record (Cat. No.01CH37310).
[63] Alan A. Wilson,et al. Positron Emission Tomography Quantification of [11C]-DASB Binding to the Human Serotonin Transporter: Modeling Strategies , 2001, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[64] R. Boellaard,et al. Experimental and clinical evaluation of iterative reconstruction (OSEM) in dynamic PET: quantitative characteristics and effects on kinetic modeling. , 2001, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[65] W. Heiss,et al. The ECAT HRRT: performance and first clinical application of the new high resolution research tomograph , 2000, 2000 IEEE Nuclear Science Symposium. Conference Record (Cat. No.00CH37149).
[66] A M Dale,et al. Measuring the thickness of the human cerebral cortex from magnetic resonance images. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[67] Alan A. Wilson,et al. Imaging the serotonin transporter with positron emission tomography: initial human studies with [11C]DAPP and [11C]DASB , 2000, European Journal of Nuclear Medicine.
[68] W. J. Lorenz,et al. Performance evaluation of the whole-body PET scanner ECAT EXACT HR + , 1997 .
[69] A. Lammertsma,et al. Simplified Reference Tissue Model for PET Receptor Studies , 1996, NeuroImage.
[70] Gunnar Brix,et al. Performance evaluation of the whole-body PET scanner ECAT EXACT HR/sup +/ , 1996, 1996 IEEE Nuclear Science Symposium. Conference Record.
[71] N. Volkow,et al. Distribution Volume Ratios without Blood Sampling from Graphical Analysis of PET Data , 1996, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[72] R. Hinz,et al. Pre- and postsynaptic serotonergic differences in males with extreme levels of impulsive aggression without callous unemotional traits: a PET study using 11C-DASB and 11C-MDL100907. , 2012 .
[73] M. Patt,et al. Preserved serotonin transporter binding in de novo Parkinson’s disease: negative correlation with the dopamine transporter , 2010, Journal of Neurology.
[74] Keishi Kitamura,et al. Performance characteristics of a new 3-dimensional continuous-emission and spiral-transmission high-sensitivity and high-resolution PET camera evaluated with the NEMA NU 2-2001 standard. , 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[75] S. Holte,et al. A preliminary evaluation of the scanditronix PC2048-15B brain scanner , 2004, European Journal of Nuclear Medicine.
[76] S. Houle,et al. Novel radiotracers for imaging the serotonin transporter by positron emission tomography: synthesis, radiosynthesis, and in vitro and ex vivo evaluation of (11)C-labeled 2-(phenylthio)araalkylamines. , 2000, Journal of medicinal chemistry.